BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6170220)

  • 21. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two new, direct, and specific methods of acid phosphatase determination. National field trial.
    Wajsman Z; Chu TM; Saroff J; Slack N; Murphy GP
    Urology; 1979 Jan; 13(1):8-11. PubMed ID: 442328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human prostatic acid phosphatases: II. A double--antibody radioimmunoassay.
    Choe BK; Pontes EJ; Morrison MK; Rose NR
    Arch Androl; 1978 May; 1(3):227-33. PubMed ID: 83815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-antibody immunoenzyme assay for human prostatic acid phosphatase.
    Choe BK; Pontes EJ; Dong MK; Rose NR
    Clin Chem; 1980 Dec; 26(13):1854-9. PubMed ID: 6159996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
    Salo JO; Rannikko S; Haapiainen R
    Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of specific antigen and prostatic acid phosphatase specificity. Study of false values.
    Morote J; Ruibal A; Palou J
    Int J Biol Markers; 1986; 1(3):141-6. PubMed ID: 2448398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radioimmunoassay kit for human prostate acid phosphatase--experimental and clinical evaluation of RIA-Quant P.A.P. Test Kit].
    Wakabayashi K; Sugiyama Y; Takahashi E; Shida K
    Kaku Igaku; 1982 Apr; 19(3):467-75. PubMed ID: 6182321
    [No Abstract]   [Full Text] [Related]  

  • 29. Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
    Cooper JF; Finkle WD
    Prostate; 1980; 1(4):441-50. PubMed ID: 7279809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
    Huber PR; Zaugg T; Linder E; Hagmaier V; Rutishauser G
    Urol Res; 1982; 10(2):75-80. PubMed ID: 6180539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase.
    Sturgeon CM; Hussey AJ; Beynon L; Ritchie A; Chisholm GD; Micklem L; James K; Seth J
    Clin Chim Acta; 1986 Nov; 161(1):47-57. PubMed ID: 2434268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J; Ruibal Morell A; De Torres Mateos JA; Soler Roselló A
    Int J Biol Markers; 1989; 4(2):87-94. PubMed ID: 2475553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J; Ruibal Morell A; Palou Redorta J; de Torres Mateos JA; Soler Roselló A
    Eur Urol; 1988; 14(5):360-6. PubMed ID: 2458936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostatic acid phosphatase by enzymeimmunoassay].
    Masukagami T; Ando K; Shimazaki J
    Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
    Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
    Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostatic acid phosphatase measured by immunoenzyme assay].
    Fuse H; Zama S; Shimazaki J
    Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
    Lindholm GR; Stirton S; Liedtke RJ; Batjer JD
    JAMA; 1980 Nov; 244(18):2071-3. PubMed ID: 6159488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.